Qube Research & Technologies Ltd

Position in IMUX — Immunic, Inc.

CIK 1729829 LONDON, X0

Position in IMUX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$123,720

+$94,906 QoQ

Shares Held

111,460

+241.2% QoQ

Ownership

0.818%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,034,188,909 across 187 Biotechnology names. IMUX ranks #164 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$123,720	111,460	+241.2%	Shares	Sole	2026-05-15
2025-09-30	$28,814	32,669	-6.6%	Shares	Sole	2025-11-14
2025-03-31	$38,138	34,989	-78.9%	Shares	Sole	2025-05-15
2024-12-31	$165,761	165,761	-5.3%	Shares	Sole	2025-02-14
2024-09-30	$288,685	174,961	+342960.8%	Shares	Sole	2024-11-14
2024-06-30	$56	51	-12.1%	Shares	Sole	2024-08-14
2023-12-31	$87	58	0.0%	Shares	Sole	2024-02-13
2023-09-30	$85	58	-99.6%	Shares	Sole	2023-11-13
2022-09-30	$45,320	14,342	-8.7%	Shares	Sole	2022-11-14
2022-06-30	$54,513	15,710	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.